Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 93Small Cell Lung Carcinoma 74Neuroblastoma 44Carcinoma, Ovarian Epithelial 43Fallopian Tube Neoplasms 41Lung Neoplasms 39Neoplasms 29Uterine Cervical Neoplasms 26Leukemia 20Brain Neoplasms 18Leukemia, Myeloid, Acute 17Recurrence 16Sarcoma 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Neoplasm Metastasis 13Lymphoma 12Central Nervous System Neoplasms 12Retinoblastoma 11Glioma 11Carcinoma, Non-Small-Cell Lung 11Sarcoma, Ewing 10Unspecified Adult Solid Tumor, Protocol Specific 8Neuroectodermal Tumors, Primitive, Peripheral 8Myelodysplastic Syndromes 8Medulloblastoma 8Endometrial Neoplasms 8Burkitt Lymphoma 8Lymphoma, Follicular 7Leukemia, Myelomonocytic, Chronic 7Blast Crisis 7

Interventions

Ifosfamide 2Etoposide 2Doxorubicin 2Cyclophosphamide 2Cisplatin 2pembrolizumab 1belinostat 1Vindesine 1Vincristine 1Topotecan 1Thoracoscopy 1Sucralfate 1Salts 1Robotic Surgical Procedures 1Rituximab 1Radiation 1Prednisolone 1Peripheral Blood Stem Cell Transplantation 1Mitozytrex 1Mitomycin 1Methotrexate 1Iodized Oil 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Ethiodized Oil 1Docetaxel 1Dexamethasone 1Cytarabine 1Carboplatin 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Mediastinal Neoplasms × Topotecan × Clear all
NCT00315211 2018-08-20

Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer

Aultman Health Foundation

Phase 2 Terminated
7 enrolled

Mediastinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡